Pharma Fights Healthcare Cost-Containment Policies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Fights Healthcare Cost-Containment Policies
The ongoing economic crisis in Europe has accelerated healthcare cost-containment measures targeting the price of pharmaceuticals, but the pharma industry is not giving in without a fight.




References

The Guardian website, “The Euro Crisis is Over, Declares José Manuel Barroso,” http://www.guardian.co.uk, accessed 15 Jan. 2013.

Reuters website, “Europe Economic Recovery Seen Mid-2013 — ECB,” http://uk.reuters.com , accessed 15 Jan. 2013.

The Telegraph website, “Europe’s Bad Debts ‘Will Bite in 2013’,” www.telegraph.co.uk, accessed 15 Jan. 2013.

EFPIA website, “Letter from EFPIA President, Sir Andrew Witty, to European Heads of States and Governments,” http://www.efpia.eu, accessed 15 Jan. 2013.

Swiss Info, “Recession-Hit Nations Owe Pharma Firms Billions,” http://www.swissinfo.ch, accessed 15 Jan. 2013.

PharmaTimes website, “Drugmakers Tell Greece: “We’ll Cap your Medicines Bill,” http://www.pharmatimes.com, accessed 15 Jan. 2013.

Business Week website, “Spain Drugmakers Plan $7 Billion Unpaid-Bill Securitization,” http://www.businessweek.com, accessed 15 Jan. 2013.

Chicago Tribune, “Spain Coughs Up Billions to Keep Regions in Medicine,” http://articles.chicagotribune.com, accessed 15 Jan. 2013.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here